MA53914A - Polymorphes cristallins d'inhibiteurs de la tyrosine kinase de bruton - Google Patents
Polymorphes cristallins d'inhibiteurs de la tyrosine kinase de brutonInfo
- Publication number
- MA53914A MA53914A MA053914A MA53914A MA53914A MA 53914 A MA53914 A MA 53914A MA 053914 A MA053914 A MA 053914A MA 53914 A MA53914 A MA 53914A MA 53914 A MA53914 A MA 53914A
- Authority
- MA
- Morocco
- Prior art keywords
- bruton
- tyrosine kinase
- kinase inhibitors
- crystalline polymorphs
- polymorphs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862745741P | 2018-10-15 | 2018-10-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA53914A true MA53914A (fr) | 2021-08-25 |
Family
ID=68426868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA053914A MA53914A (fr) | 2018-10-15 | 2019-10-15 | Polymorphes cristallins d'inhibiteurs de la tyrosine kinase de bruton |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11820760B2 (fr) |
| EP (1) | EP3866926A1 (fr) |
| JP (1) | JP7476214B2 (fr) |
| MA (1) | MA53914A (fr) |
| WO (1) | WO2020081514A1 (fr) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| RU2619465C2 (ru) | 2012-10-26 | 2017-05-16 | Ф. Хоффманн-Ля Рош Аг | Ингибиторы тирозинкиназы брутона |
| EP3060550B1 (fr) * | 2013-10-21 | 2019-05-15 | Merck Patent GmbH | Composés hétéroaryle servant d'inhibiteurs de la btk et leurs utilisations |
| CN108947913A (zh) | 2013-12-11 | 2018-12-07 | 比奥根Ma公司 | 可用于治疗人类肿瘤学、神经病学和免疫学疾病的联芳基化合物 |
| US20180282310A1 (en) | 2015-06-10 | 2018-10-04 | Biogen Ma Inc. | Forms and compositions of biaryl inhibitors of bruton's tyrosine kinase |
| JOP20190233A1 (ar) | 2017-04-14 | 2019-10-02 | Biogen Ma Inc | نظائر بنزوازيبين بوصفها عوامل مثبطة لتيروزين كيناز بروتون |
| ES2968222T3 (es) | 2018-05-14 | 2024-05-08 | Biogen Ma Inc | Agentes inhibidores para la tirosina cinasa de Bruton |
-
2019
- 2019-10-15 WO PCT/US2019/056242 patent/WO2020081514A1/fr unknown
- 2019-10-15 US US17/283,301 patent/US11820760B2/en active Active
- 2019-10-15 EP EP19797924.8A patent/EP3866926A1/fr active Pending
- 2019-10-15 MA MA053914A patent/MA53914A/fr unknown
- 2019-10-15 JP JP2021545281A patent/JP7476214B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3866926A1 (fr) | 2021-08-25 |
| JP7476214B2 (ja) | 2024-04-30 |
| US11820760B2 (en) | 2023-11-21 |
| WO2020081514A1 (fr) | 2020-04-23 |
| US20210387972A1 (en) | 2021-12-16 |
| JP2022502516A (ja) | 2022-01-11 |
| WO2020081514A9 (fr) | 2020-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3265084T3 (da) | Farmaceutiske formuleringer af Bruton's tyrosinkinase-hæmmer | |
| ZA201903932B (en) | Imidazopyrazine inhibitors of bruton's tyrosine kinase | |
| IL255831A (en) | Inhibitors of bruton's tyrosine kinase | |
| MA51066A (fr) | Inhibiteurs d'intégrine | |
| MA41350A (fr) | Synthèse d'un inhibiteur de la tyrosine kinase de bruton | |
| MA41828A (fr) | Co-cristaux d'un inhibiteur de la tyrosine kinase de bruton | |
| MA51619A (fr) | Inhibiteurs de la protéine kinase dépendante de l'adn | |
| MA51616A (fr) | Inhibiteurs d'adn-pk | |
| ZA201903694B (en) | Inhibitors of bruton's tyrosine kinase | |
| MA53226A (fr) | Sel et formes cristallines d'omecamtiv mecarbil | |
| MA41827A (fr) | Formes solvatées d'un inhibiteur de la tyrosine kinase de bruton | |
| IL259863B (en) | Polycyclic compounds as inhibitors of proton tyrosine kinase | |
| MA42510A (fr) | Formes et compositions d'inhibiteurs biaryles de la tyrosine kinase de bruton | |
| ZA201906887B (en) | Bruton's tyrosine kinase inhibitors | |
| MA52629A (fr) | Agents inhibiteurs de la tyrosine kinase de bruton | |
| MA42509A (fr) | Formes d'adipate et compositions d'inhibiteurs de biaryle de la tyrosine kinase de bruton | |
| MA51337A (fr) | Inhibiteurs spiro exo-aza de l'interaction ménine-mll | |
| MA55614A (fr) | Formes cristallines d'inhibiteur de pyridazinone trpc | |
| MA52900A (fr) | Inhibiteurs à petites molécules de la famille jak de kinases | |
| MA51283A (fr) | Dérivés de tyrosine en tant qu'inhibiteurs de kinase rho | |
| EP3882241A4 (fr) | Inhibiteur de la tyrosine kinase de bruton | |
| EA202091691A1 (ru) | ТВЕРДЫЕ ФОРМЫ ЗАМЕЩЕННЫХ 5,6-ДИГИДРО-6-ФЕНИЛБЕНЗО[f]ИЗОХИНОЛИН-2-АМИНОВЫХ СОЕДИНЕНИЙ | |
| MA53914A (fr) | Polymorphes cristallins d'inhibiteurs de la tyrosine kinase de bruton | |
| EP3966204A4 (fr) | 1-amino-1h-imidazole-5-carboxamide substitué utilisé en tant qu'inhibiteurs de la tyrosine kinase de bruton | |
| MA55964A (fr) | Agents inhibiteurs de la tyrosine kinase de bruton |